Warning letterPosted October 28, 2025

FDA warning letter to Qianjiang Kingphar Medical Material Co Ltd.

CGMP/QSR/Medical Devices/Adulterated/Misbranded

FDA's record ↗

FDA posted a warning letter to Qianjiang Kingphar Medical Material Co Ltd. on October 28, 2025; the letter is dated October 3, 2025. Subject: CGMP/QSR/Medical Devices/Adulterated/Misbranded. Issuing office: Center for Devices and Radiological Health.

On the record

Company
Qianjiang Kingphar Medical Material Co Ltd.
Subject
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Issuing office
Center for Devices and Radiological Health
Letter dated
2025-10-03
Posted by FDA
2025-10-28
Source
FDA warning letters ↗

CFR cited

The record cites 1 section of 21 CFR Part 820.

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch Qianjiang Kingphar Medical Material Co Ltd

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Qianjiang Kingphar Medical Material Co Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.